D. Padley

发表

Platelet Lysate Consisting of a Natural Repair Proteome Supports Human Mesenchymal Stem Cell Proliferation and Chromosomal Stability

A. Dietz, A. Terzic, R. Crespo-Diaz, 2011, Cell transplantation.

Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma

S. Ansell, S. Markovic, D. Gastineau, 2004, Bone Marrow Transplantation.

The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma

A. Dispenzieri, M. Gertz, S. Markovic, 2004, Leukemia.

Re-infused Autologous Graft Natural Killer Cells Correlates with Absolute Lymphocyte Count Recovery after Autologous Stem Cell Transplantation

S. Markovic, D. Gastineau, K. Bundy, 2003, Leukemia & lymphoma.

A safety study on intrathecal delivery of autologous mesenchymal stromal cells in rabbits directly supporting Phase I human trials

N. Staff, A. Dietz, J. Parisi, 2015, Transfusion.

decitabine vorinostat and haploidentical natural killer cell infusions with il 2 atimulation in high risk myelodysplastic syndrome

M. Patnaik, J. Miller, D. McKenna, 2018 .

Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML.

P. Bulur, S. Vuk-Pavlović, A. Tefferi, 2006, Cytotherapy.

Infusion technique of hematopoietic progenitor cells and related adverse events (CME)

W. Hogan, D. Gastineau, S. Bryant, 2014, Transfusion.

Concurrent comparison of the cobe spectra and fenwal CS3000 for the collection of peripheral blood mononuclear cells for autologous peripheral stem cell transplantation

R. Strauss, M. Randels, D. Padley, 1991, Journal of clinical apheresis.

Essential requirements for setting up a stem cell processing laboratory

D. Niederwieser, F. Lanza, C. Chabannon, 2014, Bone Marrow Transplantation.

Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery.

M. Trigg, R. Giller, F. Goldman, 1996, Blood.

Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations

R. Strauss, R. Gingrich, F. Koontz, 1996, Transfusion.

recovery immunophenotypic analysis and factors affecting the speed of matched T-cell-depleted bone marrow transplantation in children: Reconstruction of the immune system after unrelated or partially

M. Trigg, R. Giller, F. Goldman, 2011 .

Idiotype‐pulsed antigen presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival

S. Mandrekar, D. Dingli, A. Dispenzieri, 2009, American journal of hematology.

Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.

J. Buckner, S. Vuk-Pavlović, M. Peshwa, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma

A. Dietz, S. Vuk-Pavlović, J. Ingle, 2006, Journal of Translational Medicine.

Low rejection rate when using unrelated or haploidentical donors for children with leukemia undergoing marrow transplantation.

M. Trigg, R. Gingrich, R. Giller, 1989, Bone marrow transplantation.

Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphocyte collection target

D. Gastineau, J. Winters, S. Moore, 2006, Bone Marrow Transplantation.

Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients

A. Dietz, D. Visscher, T. Hobday, 2018, Clinical Cancer Research.

Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanoma.

S. Vuk-Pavlović, D. Gastineau, G. Butler, 2004, Cytotherapy.

Mature myeloid dendritic cells for clinical use prepared from CD14+ cells isolated by immunomagnetic adsorption.

S. Vuk-Pavlović, D. Gastineau, D. Padley, 2001, Journal of hematotherapy & stem cell research.

Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.

R. Vile, Lieping Chen, J. Kasperbauer, 2002, Cancer research.

Infrastructure Development for Human Cell Therapy Translation

D. Gastineau, A B Dietz, D A Gastineau, 2007, Clinical pharmacology and therapeutics.

AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphoma.

S. Markovic, D. Gastineau, D. Inwards, 2007, Clinical lymphoma & myeloma.

Sterility testing of hematopoietic progenitor cell products: a single‐institution series of culture‐positive rates and successful infusion of culture‐positive products

A. Dietz, D. Gastineau, D. Padley, 2007, Transfusion.

Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope Vaccine

A. Dietz, A. Degnim, A. Dueck, 2019, Clinical Cancer Research.

Endogenous microbial contamination of cultured autologous preparations in trials of cancer immunotherapy.

D. Gastineau, M. K. Hopkins, D. Padley, 2003, Cytotherapy.

Effect of AMD3100 on T Lymphocyte Subpopulations in Apheresis Products of Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Non Hodgkin Lymphoma.

A. Dispenzieri, Shaji K. Kumar, M. Gertz, 2005 .

Rapid Communication Mature Myeloid Dendritic Cells for Clinical Use Prepared from CD14 1 Cells Isolated by Immunomagnetic Adsorption

A. Dietz, S. Vuk-Pavlović, D. Gastineau, 2001 .

Discordant CD34+ cell results in peripheral blood and hematopoietic progenitor cell–apheresis product: implications for clinical decisions and impact on patient treatment

M. Gustafson, D. Gastineau, J. Winters, 2014, Transfusion.